Claire, Recipient of the Benson Research Fellowship: One Step Closer to a Cure
For Dr. Claireย Bergstromย Johnson, becoming a scientist wasn't just a career choiceโit was personal. When herโฆ
CIDP Real-World Experience
Research Study Opportunity: CIDP Real-World Experience For more information: https://cidpresearchstudy.com/ A new research study isโฆ
Novel Key Terms For Managing CIDP Published in Neurology Journal
CONSHOHOCKEN, PA โ The GBS|CIDP Foundation International is thrilled to announce the publication of sharedโฆ
Speaker Series: Foundation Funded Research Grants
This speaker series will highlight the mission and impact behind our Foundation-funded grants program, exploringโฆ
Benson Clinical Research Fellowship
Claire Bergstrom Johnson My decision to apply for the Benson Fellowship stems from my commitmentโฆ
Leadership Collaborative
The first biennial GBS|CIDP Foundation Leadership Collaborative convened in Boston! Every two years, the Foundation will bringโฆ
How You Can Manage Fatigue
Submitted by Dr. Gareth Parry, Global Medical Advisory Board Member and GBS Support Group NZโฆ
Research Article: Pathogenesis of GBS based on mice strains
Development of a major histocompatibility complex class II conditional knockout mouse to study cell-specific andโฆ
2024 MMN Research Grant Announcement
In 2022, the Foundation embarked on fundraising endeavors aimed at research dedicated to advancing treatmentsโฆ
Inspiring the Next Generation of Research at the GBS|CIDP Foundation International Patient Symposiumย ย
As part of the 2023 International Patient Symposium, the Foundation was thrilled to welcome sevenโฆ
A one-year Research Update from the 2022 Benson Fellowship Awardee
A one-year Research Update from the 2022 Benson Fellowship Awardee, Elba Pascual-Goรฑi MD, PhD. ย โฆ
Children with rapid-onset paralysis: is it GBS?
Children with rapid-onset paralysis: is it GBS? by Patricia Blomkwist An interesting article* was publishedโฆ
Announcing 2022 Benson Fellowship Awardee
Announcing 2022 Benson Fellowship Awardee, Elba Pascual Goรฑi MD, PhD The Benson Fellowship is aโฆ
An Update from the International Guillain-Barre Study (IGOS) by Dr. Bart Jacobs
The IGOS-1000 cohort has now been tested for the main preceding infections and is currentlyโฆ
New Study Reveals No Association Between COVID-19 and Guillain-Barrรฉ Syndrome
The GBS|CIDP Foundation is committed to sharing the most accurate information from the worldโs leadingโฆ
2018 GBS|CIDP Foundation Research Grant Recipient Publishes Update in Journal of Neurology, Neurosurgery & Psychology
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP andโฆ
Foundation Hosted Patient Listening Session on Guillain-Barre Syndrome with The FDA
On September 29, 2020, the GBS|CIDP Foundation International organized a patient-led listening session on Guillain-Barreโฆ
Your Donations in Action
Findings of 2016 GBS|CIDP Research Grant Support Article Published by EAN In 2016 The GBS|CIDPโฆ
INCbase
INCbase Update Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder that affects different peopleโฆ
2020 GBS|CIDP Foundation International Research Grants Announced!
Research grants are made possible through the benevolence of many sources, including the Helen S.โฆ
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Update from the International GuillainโBarrรฉ Syndrome Outcome Study (IGOS)
Diagnosis and management of GuillainโBarrรฉ syndrome in ten steps Portugueseย Spanishย Chinese Nature Reviews Neurology: https://www.nature.com/articles/s41582-019-0250-9; Published Sept 20,โฆ
New Research Grant Announced: Exploring possible role of TGR5 and FXR in autoimmune neuropathy
Please join us in congratulating, 2019 GBS|CIDP Research Grant Recipient, Betty Soliven, MD for herโฆ
Announcing 2019 GBS|CIDP Research Grant Awardee, Ruth Huizinga, PhD, Assistant Professor, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Please join us in congratulating, 2019 GBS|CIDP Research Grant Recipient, Ruth Huizinga, PhD, Assistant professor,โฆ
Please join us in Congratulating 2019 GBS|CIDP Foundation Research Grant Recipient, Dr. Eduardo Nobile-Orazio
Study Description: A randomized controlled trial with Rituximab versus placebo in patients with chronic inflammatoryโฆ
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Published in The Lancet, May 7, 2019Co-authored by Carina Bunschoten, Bart C Jacobs, Peter Uโฆ
Dr. Bart Jacobs, Vice Chairman of GMAB, and co-authors, โEditorโs Choice,โ Brain Journal
Regional variation of Guillain-Barrรฉ syndrome Brain, Volume 141, Issue 10, 1 October 2018, Pages 2866โ2877โฆ
CIDP Disease Burden โ Results of a US Nationwide Patient Survey
In 2017, a nationwide survey of US CIDP patients was conducted to assess the impactโฆ
Research in CIDP: Are we making progress?
By Jeffrey A. Allen, MDMember, GBS|CIDP Foundation Global Medical Advisory Board CIDP as a namedโฆ
Subcutaneous Immunoglobulin: A Newly Approved Treatment Option for CIDP
David Saperstein, MDCo-Director GBS/CIDP Center of ExcellencePhoenix Neurological AssociatesPhoenix, AZ Intravenous immunoglobulin (IVIg) is oneโฆ